Pediatric Oncology

Top Story

Many patients lack knowledge about advances in cancer diagnostics, treatment

Many patients lack knowledge about advances in cancer diagnostics, treatment
February 22, 2017

A majority of patients with cancer and their caregivers lack sufficient knowledge about advances in diagnostic and treatment options, according to results of a survey released by Cancer Treatment Centers of America.

Approximately 80% of patients and caregivers who responded indicated they are generally satisfied with the quality of care they have received. However, more than two-thirds reported they have limited knowledge about the newest treatment options and diagnostic tools.

In the Journals Plus

Many nonelderly cancer survivors alter prescription drug use to save money

February 21, 2017
Nearly one-third of nonelderly Americans recently diagnosed with cancer change their prescription drug use for financial reasons, according to an analysis published in…

Society leaders: 2017 likely to be time of ‘unprecedented’ advances in hematology, oncology

February 20, 2017
This calendar year could be a pivotal one for oncology and hematology research, drug approvals and clinical trial results. In 2016, several new immunotherapies…

Five articles that raise awareness about persistent clinical trial disparities

February 17, 2017
Clinical trials contribute to the overall understanding of cancer biology and help to advance treatment options and improve patient outcomes. However, gaps among…
CME

Management of Multiple Myeloma: Using Emerging Therapies with ASCT

This activity is supported by educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Spectrum Pharmaceuticals, Inc.; and Takeda Oncology.

Multiple myeloma management has undergone profound changes in the past few decades, this is largely due to advances in…
More »
Video
Meeting News Coverage

VIDEO: Early intervention reduces severe cytokine release syndrome after CD19 CAR T-cell therapy

December 3, 2016
More »
Featured
CME

Combination Strategies in Melanoma Management: What’s New and What’s Next

This activity is supported by an educational grant from Genentech, Inc.

Melanoma is the sixth most common cancer in the United States and the deadliest form of skin cancer. Although it is…
More »

Many patients lack knowledge about advances in cancer diagnostics, treatment

February 22, 2017
A majority of patients with cancer and their caregivers lack sufficient knowledge about advances in diagnostic and treatment options, according to…

In the Journals Plus

Many nonelderly cancer survivors alter prescription drug use to save money

February 21, 2017
Nearly one-third of nonelderly Americans recently diagnosed with cancer change their prescription drug use for financial reasons, according to an…

Society leaders: 2017 likely to be time of ‘unprecedented’ advances in hematology, oncology

February 20, 2017
This calendar year could be a pivotal one for oncology and hematology research, drug approvals and clinical trial results. In 2016, several new…

Five articles that raise awareness about persistent clinical trial disparities

February 17, 2017
Clinical trials contribute to the overall understanding of cancer biology and help to advance treatment options and improve patient outcomes…

In the Journals

Pregnancy in survivors of childhood cancer may confer elevated risk for cardiotoxicity

February 17, 2017
Pregnancy may be linked to an increased risk for cardiotoxicity in patients who survived cancer in childhood, according to a research letter…

FDA: More adolescents with cancer should be included in adult trials

February 13, 2017
Enrollment of adolescents in oncology trials remains significantly lower than that of children. Consequently, the FDA has urged the research…

In the Journals Plus

Use of metaphors may improve participation in clinical trials

February 11, 2017
The use of metaphors for explaining randomization could ease the difficulty in recruiting patients to participate in randomized clinical trials…

‘Explosive growth’ of interventional oncology prompts formation of new society

February 10, 2017
The board of directors for World Conference on Interventional Oncology, a nonprofit association that supports and promotes the field, has established…

Eight updates in cancer prevention

February 10, 2017
National Cancer Prevention Month, established by a U.S. Senate resolution and observed every February since 2004, is intended to draw attention to…

Payment reform, ‘runaway growth’ of 340B top new Community Oncology Alliance president’s priorities

February 9, 2017
Jeff Vacirca, MD, FACP, CEO and managing director of clinical research at New York Cancer Specialists in Long Island, N.Y., has been elected…

More Headlines »
Advertisement
Advertisement